使用经皮心肺支持治疗暴发性心肌炎合并心源性休克患者以改善预后。
Use of percutaneous cardiopulmonary support of patients with fulminant myocarditis and cardiogenic shock for improving prognosis.
作者信息
Kato S, Morimoto S, Hiramitsu S, Nomura M, Ito T, Hishida H
机构信息
Department of Internal Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
出版信息
Am J Cardiol. 1999 Feb 15;83(4):623-5, A10. doi: 10.1016/s0002-9149(98)00931-x.
Abstract
Percutaneous cardiopulmonary support was used in 9 patients with fulminant myocarditis and cardiogenic shock. Although 2 of the patients died, 7 improved and were able to resume social activities. Percutaneous cardiopulmonary support should be administered routinely to patients with fulminant myocarditis developing into cardiogenic shock.
摘要
9例暴发性心肌炎合并心源性休克患者接受了体外膜肺氧合支持治疗。尽管有2例患者死亡，但7例病情好转并能够恢复社交活动。对于发展为心源性休克的暴发性心肌炎患者，应常规给予体外膜肺氧合支持治疗。
Zotero 插件